Cancer
Malignant Cervical Neoplasm
CI-CAN-00007992Explore in graph →
Top-level506 active trials4 approved drugs14 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00007992Explore in graph →
Clinical trials
1,994 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (181)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05779111 | A Retrospective Analysis: Whether Five Factors Affect PFS in Patients With Locally Advanced Cervical Cancer | completed | — | 183 | Chongqing University Cancer HospitalOTHER | 1 | Mar 22, 2023 | clinicaltrials |
| NCT03307044 | Fractional CO2 Laser Therapy for Survivors of Breast Malignancies | completed | N/A | 66 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Mar 20, 2023 |
| NCT04837677 | A Study of PRT1419 in Patients With Advanced Solid Tumors | completed | Phase 1 | 26 | Prelude TherapeuticsINDUSTRY | 1 | Mar 15, 2023 | clinicaltrials |
| NCT01399658 | Image-Guided Gynecologic Brachytherapy(AMIGO) | completed | Phase 2 | 93 | Dana-Farber Cancer InstituteOTHER | 1 | Mar 14, 2023 | clinicaltrials |
| NCT05767138 | STI Knowledge and HPV Vaccine Acceptance in Bamako, Mali in 2012 | completed | — | 301 | Global Alliance to Immunize Against AIDS Vaccine FoundationOTHER | 0 | Mar 14, 2023 | clinicaltrials |
| NCT05746156 | Lymphatic Mapping for Image Guided Radiotherapy in Patients With LACC - a Feasibility Study(LaMA) | completed | N/A | 17 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Feb 27, 2023 | clinicaltrials |
| NCT02921269 | Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer | completed | Phase 2 | 11 | National Cancer Institute (NCI)NIH | 1 | Feb 21, 2023 | clinicaltrials |
| NCT05736315 | Use of a Fermented Dairy Beverage in Cervical Cancer Patients Undergoing Concurrent Chemoradiation Therapy | completed | N/A | 42 | National Institute of CancerologíaOTHER_GOV | 1 | Feb 21, 2023 | clinicaltrials |
| NCT05717751 | Predictors of Para-aortic Lymph Node Metastasis of Cervical Cancer | completed | — | 452 | Chongqing University Cancer HospitalOTHER | 1 | Feb 8, 2023 | clinicaltrials |
| NCT04246580 | Evaluation of Indocyanine Green-guided Systematic Pelvic Lymphadenectomy in Endometrial and Cervical Cancer | completed | — | 230 | Università degli Studi dell'InsubriaOTHER | 0 | Jan 31, 2023 | clinicaltrials |
| NCT02025985 | Study of KPT-330 (Selinexor) in Female Patients With Advanced Gynaecologic Malignancies(SIGN) | completed | Phase 2 | 116 | Karyopharm Therapeutics IncINDUSTRY | 2 | Jan 26, 2023 | clinicaltrials |
| NCT02428842 | Biomarker Evaluation in Advanced Stage Cervical Cancer by an International Working Group. Tumor Stages (1B1 - 4)(BIO-RAIDs) | completed | N/A | 419 | Institut CurieOTHER | 5 | Jan 20, 2023 | clinicaltrials |
| NCT04430842 | Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S | completed | Phase 1 | 15 | Quadriga Biosciences, Inc.INDUSTRY | 1 | Jan 18, 2023 | clinicaltrials |
| NCT02774538 | Agreement Between Oral and Cervical Human Papillomavirus Infection in a French Cohort(PAPILLOR) | completed | N/A | 165 | Institut de Cancérologie de LorraineOTHER | 1 | Dec 19, 2022 | clinicaltrials |
| NCT02651883 | Effect of Human Papillomavirus Self-Collection on Cervical Cancer Screening in High Risk Women: My Body, My Test 3(MBMT-3) | completed | N/A | 665 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Dec 2, 2022 | clinicaltrials |
| NCT03517488 | A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors(DUET-2) | completed | Phase 1 | 150 | Xencor, Inc.INDUSTRY | 1 | Dec 1, 2022 | clinicaltrials |
| NCT05388162 | A Non-inferiority Evaluation of a Smart-phone Based Cervical Imaging Device. | completed | N/A | 26 | Scripps HealthOTHER | 1 | Nov 22, 2022 | clinicaltrials |
| NCT03713710 | Self-Sampling for Human Papillomavirus (HPV) Testing in African American Women - Mississippi Delta(HPV) | completed | N/A | 335 | University of Alabama at BirminghamOTHER | 1 | Nov 16, 2022 | clinicaltrials |
| NCT01693783 | Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer | completed | Phase 2 | 42 | National Cancer Institute (NCI)NIH | 2 | Nov 8, 2022 | clinicaltrials |
| NCT01414608 | Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer | completed | Phase 3 | 926 | GOG FoundationNETWORK | 5 | Nov 7, 2022 | clinicaltrials |
| NCT04000503 | Integrated Cervical Cancer Screening in Mayuge District Uganda (ASPIRE Mayuge)(ASPIRE) | completed | N/A | 2,019 | University of British ColumbiaOTHER | 1 | Nov 3, 2022 | clinicaltrials |
| NCT01097746 | First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer | completed | Phase 2 | 33 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 28, 2022 | clinicaltrials |
| NCT04421131 | mHealth-supported Telecolposcopy for Cervical Cancer Programs in Low-resource Settings: Evaluation (mIVAA) | completed | N/A | 112 | Duke UniversityOTHER | 1 | Oct 17, 2022 | clinicaltrials |
| NCT01975831 | A Phase 1 Study to Evaluate MEDI4736 in Combination With Tremelimumab | completed | Phase 1 | 104 | Ludwig Institute for Cancer ResearchOTHER | 1 | Oct 12, 2022 | clinicaltrials |
| NCT01760850 | Breast and Cervical Cancer Educational Intervention for Latinas in Western New York | completed | N/A | 959 | Roswell Park Cancer InstituteOTHER | 1 | Oct 5, 2022 | clinicaltrials |
| NCT00943722 | A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002) | completed | Phase 3 | 3,074 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Oct 3, 2022 | clinicaltrials |
| NCT05539274 | Cervical Carcinoma in Shatby University Hospital and Its Relation to Human Papilloma Virus | completed | — | 70 | Hossam Hassan Aly Hassan El SokkaryOTHER | 1 | Oct 3, 2022 | clinicaltrials |
| NCT04612660 | HPV Self-test to Increase Cervical Cancer Screening in Asian Women | completed | N/A | 156 | Temple UniversityOTHER | 1 | Sep 30, 2022 | clinicaltrials |
| NCT05537012 | Incidence of Unresectable Cases of Cervical Cancer | completed | — | 70 | HOSSAM ALSUKARIOTHER | 1 | Sep 13, 2022 | clinicaltrials |
| NCT05511740 | Circadian as A Prognostic Factor For Radiation Response in Cervical Cancer | completed | N/A | 71 | Indonesia UniversityOTHER | 0 | Aug 23, 2022 | clinicaltrials |
| NCT04064515 | CTCs in Cervix Cancer | completed | — | 4 | NYU Langone HealthOTHER | 1 | Aug 5, 2022 | clinicaltrials |
| NCT03604653 | Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers | completed | — | 10 | Holy Name Medical Center, Inc.OTHER | 1 | Aug 3, 2022 | clinicaltrials |
| NCT01590017 | Cisplatin and Radiation Therapy in Treating Patients With HIV-Associated Locally Advanced Cervical Cancer | completed | Phase 2 | 41 | AIDS Malignancy ConsortiumNETWORK | 2 | Jul 27, 2022 | clinicaltrials |
| NCT05476341 | A Phase I Clinical Trial of Bevacizumab Injection | completed | Phase 1 | 98 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Jul 27, 2022 | clinicaltrials |
| NCT04208724 | Support Program for Adoption of Cancer Screening Interventions at a Rural Community-Based Organization | completed | N/A | 35 | Fred Hutchinson Cancer CenterOTHER | 1 | Jul 26, 2022 | clinicaltrials |
| NCT02206048 | Use of High-Resolution Microendoscopy (HRME) in Patients With Adenocarcinoma In-Situ (AIS) of the Cervix | completed | N/A | 9 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 25, 2022 | clinicaltrials |
| NCT01470677 | Tachosil for the Prevention of Symptomatic Lymph Cysts | completed | Phase 3 | 220 | Ruhr University of BochumOTHER | 2 | Jul 8, 2022 | clinicaltrials |
| NCT05426148 | Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female | completed | Phase 4 | 540 | Xiamen Innovax Biotech Co., LtdINDUSTRY | 1 | Jun 29, 2022 | clinicaltrials |
| NCT04630327 | Validation of the Russian and Kazakh Versions of the Beck Depression Inventory and Beck Anxiety Inventory | completed | — | 226 | Kazakh Medical University of Continuing EducationOTHER | 1 | Jun 21, 2022 | clinicaltrials |
| NCT03476018 | Trial to Optimally Show the Pharmacological Action of Z-100 | completed | Phase 3 | 72 | Zeria PharmaceuticalINDUSTRY | 1 | Jun 16, 2022 | clinicaltrials |
| NCT01672892 | Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer | completed | Phase 3 | 289 | Radiation Therapy Oncology GroupNETWORK | 4 | Jun 15, 2022 | clinicaltrials |
| NCT04530201 | CASUS: Validation for Detection of Precursor Lesions(CASUS-WP4) | completed | N/A | 332 | Universiteit AntwerpenOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT03540069 | Reducing Barriers and Sustaining Utilization of a Cervical Cancer Screening Program in Rural Senegal | completed | N/A | 160 | University of Illinois at ChicagoOTHER | 2 | Jun 14, 2022 | clinicaltrials |
| NCT04155294 | Re-Evaluation of Annual Cytology Using HPV Testing to Upgrade Prevention in Women Living With HIV(REACH-UP) | completed | — | 71 | University of OxfordOTHER | 1 | May 24, 2022 | clinicaltrials |
| NCT05384366 | Neoadjuvant Chemotherapy in Cervical Cancer | completed | Phase 3 | 33 | Banaras Hindu UniversityOTHER | 1 | May 20, 2022 | clinicaltrials |
| NCT02272075 | SmartScope vs Standard Colposcope for the Evaluation of Cervical Dysplasia | completed | N/A | 30 | Scripps HealthOTHER | 1 | May 17, 2022 | clinicaltrials |
| NCT04088786 | Phase I Trial HIPEC With Nal-irinotecan | completed | Phase 1 | 18 | Stony Brook UniversityOTHER | 1 | May 6, 2022 | clinicaltrials |
| NCT04436133 | Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) | completed | Phase 2 | 480 | National Vaccine and Serum Institute, ChinaINDUSTRY | 1 | May 6, 2022 | clinicaltrials |
| NCT03372720 | Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors | completed | N/A | 19 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Apr 22, 2022 | clinicaltrials |
| NCT03873376 | Self-sampling Among Long-term Non-attenders to Cervical Cancer Screening | completed | N/A | 5,669 | Oslo University HospitalOTHER | 1 | Apr 21, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Mar 22, 2023source: clinicaltrials